Position in PFE
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$442,494
-$78,811 QoQ
Shares Held
18,376
-1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,844
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Archford Capital Strategies, LLC holds $29,267,302 across 10 Drug Manufacturers - General names. PFE ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
40,636 | $10,320,324 | |
| 2 | NVS |
Novartis AG
|
49,908 | $7,821,581 | |
| 3 | MRK |
Merck & Co., Inc.
|
27,354 | $3,514,989 | |
| 4 | LLY |
ELI LILLY & Co
|
2,586 | $3,101,726 | |
| 5 | ABBV |
AbbVie Inc.
|
6,013 | $1,513,111 | |
| 6 | SNY |
Sanofi
|
33,227 | $1,417,463 | |
| 7 | AZN |
Astrazeneca PLC
|
2,652 | $502,872 | |
| 8 | PFE |
Pfizer Inc
This page
|
18,376 | $442,494 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $442,494 | 18,376 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $521,305 | 18,565 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $372,553 | 14,962 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $415,222 | 16,296 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $474,788 | 19,587 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $397,863 | 15,701 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $435,940 | 16,432 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $492,414 | 17,015 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $536,096 | 19,160 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $550,143 | 19,825 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $567,738 | 19,720 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $1,114,213 | 33,591 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,254,602 | 34,204 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,424,124 | 34,905 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,648,647 | 32,175 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $1,317,307 | 30,103 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,546,737 | 29,501 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $1,376,150 | 26,582 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $1,386,434 | 23,479 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $909,360 | 21,143 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $781,320 | 19,952 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $737,316 | 20,351 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $1,565,971 | 42,542 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,530,938 | 41,715 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $1,332,918 | 40,762 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $1,338,629 | 41,012 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||